Cell and Gene Therapy Catapult

Building collaborative relationships to overcome challenges in the CGT industry 2:46
Building collaborative relationships to overcome challenges in the CGT industry
Sharon Brownlow • 26 Jan 2022
Achieving operational excellence in CGT through automation 4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow • 26 Jan 2022
Increasing recruitment in the cell and gene therapy sector 5:07
Increasing recruitment in the cell and gene therapy sector
Sharon Brownlow • 26 Jan 2022
Educating and training clinicians on advanced therapies 1:42
Educating and training clinicians on advanced therapies
Sharon Brownlow • 26 Jan 2022
Addressing remaining barriers to the commercialization of ATMPs 2:07
Addressing remaining barriers to the commercialization of ATMPs
Matthew Durdy • 6 Oct 2021
The evolving landscape of autologous and allogeneic therapies 1:44
The evolving landscape of autologous and allogeneic therapies
Matthew Durdy • 6 Oct 2021
What can the advanced therapies industry learn from the COVID-19 pandemic? 1:44
What can the advanced therapies industry learn from the COVID-19 pandemic?
Matthew Durdy • 6 Oct 2021
An update on the UK Cell and Gene Therapy Catapult 2:21
An update on the UK Cell and Gene Therapy Catapult
Matthew Durdy • 6 Oct 2021
The current landscape of advanced therapies in the UK 1:34
The current landscape of advanced therapies in the UK
Matthew Durdy • 6 Oct 2021
Building the advanced therapies workforce in the UK 4:25
Building the advanced therapies workforce in the UK
Matthew Durdy • 9 Apr 2021
The state of investment in cell & gene therapy 3:31
The state of investment in cell & gene therapy
Matthew Durdy • 9 Apr 2021
Shaping the future of CMC in cell & gene therapy 4:06
Shaping the future of CMC in cell & gene therapy
Stephen Ward • 14 Apr 2021
Advancing the sector: training, scalability & materials standardization 3:24
Advancing the sector: training, scalability & materials standardization
Stephen Ward • 14 Apr 2021
Horizon scanning for the UK cell & gene therapy sector 3:43
Horizon scanning for the UK cell & gene therapy sector
Stephen Ward • 14 Apr 2021
The lasting impact of COVID-19 on the CGT sector 3:10
The lasting impact of COVID-19 on the CGT sector
Stephen Ward • 14 Apr 2021
Tackling manufacturing challenges in advanced therapies 3:35
Tackling manufacturing challenges in advanced therapies
Matthew Durdy • 9 Apr 2021
The content of VJRegenMed is intended for healthcare professionals